Article Information
History
- September 6, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Davies O. Kimanga1,*,§,
- Valeria N.B. Makory2,*,
- Amin S. Hassan3,
- Faith Ngari2,
- Margaret M. Ndisha1,
- Kennedy J. Muthoka4,
- Lydia Odero5,
- Gonza O. Omoro6,
- Appolonia Aoko1 and
- Lucy Ng’ang’a1
- 1Division for Global HIV & TB (DGHT), Center for Global Health, US Centres for Disease Control and Prevention (CDC), Nairobi, Kenya
- 2National AIDS and STI Control Program (NASCOP), Ministry of Health, Nairobi, Kenya
- 3KEMRI/Wellcome Trust Research Programme, Kilifi, Kenya
- 4Epidemiology and Data Use, Palladium Group, Nairobi, Kenya
- 5Health Population and Nutrition, United States Agency for International Development (USAID), Nairobi, Kenya
- 6Strategic Information, Military HIV Research Program/Walter Reed Army Institute of Research (MHRP/WRAIR), Nairobi, Kenya
- ↵§Corresponding Author:
Dr. Davies O. Kimanga, P. O. Box 606 - 00621 Nairobi, Kenya, E-mail: npm1{at}cdc.gov
↵* Authors with equal contribution
Posted September 06, 2023.
IMPACT OF THE COVID-19 PANDEMIC ON ROUTINE HIV CARE AND ANTIRETROVIRAL TREATMENT OUTCOMES IN KENYA: A NATIONALLY REPRESENTATIVE ANALYSIS
